News & Updates

Supplementation with krill oil does not appear to produce significant improvements in knee pain in individuals with knee osteoarthritis, as shown in a study.

Topiramate demonstrates similar efficacy and safety as first-line naltrexone in the management of alcohol use disorder (AUD) and appears to be better in reducing other clinical outcomes, reports a study.

The monoclonal antibody pamrevlumab does not appear to improve outcomes for patients with idiopathic pulmonary fibrosis when compared with placebo, according to the phase III ZEPHYRUS-1 trial.

Certain factors, such as ease of connectivity and timing, influence the experience of patients and caregivers with telepharmacy in cancer care, a study has found.

The use of blood pressure (BP)-lowering medications may slightly raise the incidence of eczematous dermatitis among older adults, with the magnitude of effect being largest for calcium channel blockers and diuretic drugs and smallest for angiotensin-converting enzyme (ACE) inhibitors and β-blockers, according to a study.

Supplementation with vitamin B may or may not reduce the risk of certain cancers, with varying effects depending on the type of cancer and vitamin B compounds, according to a study.

Pooled analysis of the ASSERT and ASSERT-EXT studies show sustained improvements in multiple parameters with odevixibat in individuals with Alagille syndrome (ALGS), thus reinforcing its role in the treatment of this multisystem genetic disorder.